Tourmaline Bio, Inc. - Common stock, par value $0.0001 per share (TRML)

Historical Holders from Q4 2023 to Q3 2025

Symbol
TRML
Type / Class
Equity / Common stock, par value $0.0001 per share
Shares outstanding
25.7M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
21.6M
Holdings value
$1.03B
% of all portfolios
0.005%
Grand Portfolio weight change
+0%
Number of holders
134
Number of buys
73
Number of sells
-70
Average Value change %
0%
Average buys %
+0.003%
Average sells %
-0.004%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Tourmaline Bio, Inc. - Common stock, par value $0.0001 per share (TRML)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Avoro Capital Advisors LLC 9.95% $41.4M 2.56M Avoro Capital Advisors LLC 30 Jun 2025
QVT Financial LP 8.39% +44.2% $34.9M $11M 2.15M +46.2% QVT Financial LP 30 Jun 2025
BlackRock, Inc. 5.5% $67.5M 1.41M BlackRock, Inc. 30 Sep 2025
Blue Owl Capital Holdings LP 4.2% $18.7M 1.08M Blue Owl Capital Holdings LP 31 Dec 2024

Institutional Holders of Tourmaline Bio, Inc. - Common stock, par value $0.0001 per share (TRML)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 21.6M $1.03B +$121M $47.83 134
2025 Q2 24.1M $385M +$2.89M $15.99 107
2025 Q1 23.9M $364M +$11.4M $15.21 107
2024 Q4 22.9M $464M +$8.43M $20.28 100
2024 Q3 21M $541M +$2.11M $25.71 90
2024 Q2 21.2M $272M -$49.2M $12.86 83
2024 Q1 20.6M $470M +$169M $22.90 95
2023 Q4 13M $338M +$338M $26.18 54